Estrada-Correa G, Molina-Carrión LE, Ysita-Morales A

Language: Spanish
References: 17
Page: 469-472
PDF size: 136.81 Kb.

ABSTRACT

Introduction: the sarcoidosis is a granulomatous, multisystemic disease, of unknown etiology that mainly affects the lungs, skin and lymphatic ganglia. The definitive diagnosis is made by the presence of granulomas non-caseous in diverse organs. Sarcoidosis is rare in Mexico and reports of its incidence do not exist. In Spain the incidence is low (1.2 to 1.5 cases by 100,000 inhabitants). In the United States incidence is 5.9 to 6.3 cases by 100,000 inhabitants (males and females respectively). Neurosarcoidosis is present in 5 to 26% of all the patients with sarcoidosis. The neurological manifestations are diverse, depending on the location site.
Clinical case: we present the case of a male 33 years old, with recurrent facial paralysis, optic neuritis and affection of the third cranial nerve; the tomography of skull reveled an grow of left cavernous sinus and reinforcing bilateral temporal giral, and the nuclear magnetic resonance showed leptomeningeal reinforcing in the temporal lobe.
Conclusion: although the neurosarcoidosis is rare in Mexico, it should be considered in patients with suggestive clinical manifestations and compatible imaging findings. It should be done an intense search of systemic affection with biopsy and verification of non-caseous gra-nulomas.

REFERENCES

1. Moller DR, Chen ES. What causes sarcoidosis? Curr Opin Pulm Med 2002;8:445-451.

2. Arévalo-López A, Macotela-Ruiz E. Sarcoidosis (intra y extratorácica): a propósito de un caso mexicano. Gac Med Mex 1991;127:411-417.

3. Fité E, Alsina JM, Mana J, Pujol R, Morera J. Epidemiology of sarcoidosis in Catalonia: 1979-1989. Sarcoidosis Vasc Diffuse Lung Dis 1996;13:153-158.

4. Henke CE, Henke G, Elveback LR, Beard CM, Ballard DJ, Kurland LT. The epidemiology of sarcoidosis in Rochester, Minnesota: a population based study of incidence and survival. Am J Epidemiol 1986;123:840-845.

5. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol 1985;42:909-917.

6. Allen RKA, Sellars RE, Sandstrom PA. A prospective study of 32 patients with neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20:118-125.

7. Ortega MD, Tintoré M, Montalbán X, Codina A, Rovira A. Afectación intracraneal en la neurosarcoidosis: descripción de cuatro casos como manifestación inicial de la enfermedad. Rev Neurol 1999;28:491-494.

8. Stern BJ. Neurological complications of sarcoidosis. Curr Opin Neurol 2004;17: 311-316.

9. Nowak DA, Widenka DC. Neurosarcoidois: a review of its intracranial manifestation. J Neurol 2001;248:363-372.

10. James DG. Differential diagnosis of facial nerve palsy. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14:115-120.

11. Lower EE, Broderick JP, Brott TG, Baughmann RP. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997;157:1864-1868.

12. Zajicek JP, Scolding NJ, Foster O, et al. Central nervous system sarcoidosis: diagnosis and management. Q J Med 1999;92:103-117.

13. Nowak DA, Gumprecht H, Widenka DC, Stolzle A, Lumenta CB. Solitary sarcoid granulomatosis mimicking meningioma. J Neurosurg 2000;93: 897.

14. 14 . Saboor S, Johsson N, McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 1992;339:1012-1015

15. Joseph R, Lynch JP III. Neurosarcoidosis: how good are the diagnostic tests? J Neuroophthalmol 2003;23:187-189.

16. Manterola-Burgaleta A, Teijeira-García M, Dueñas-Polo MT. Neurosarcoidosis. A propósito de un caso y revisión de la literatura. Rev Neurol 2001;32:57-59.

17. Kang S, Suh JH. Radiation therapy for neurosarcoidosis: report of three cases from a single institution. Radiat Oncol Invest 1999;7:309-312.